Mitochondrial DNA leakage (mtDNA leakage)

Mitochondrial DNA (mtDNA) leakage is a biological process characterized by the release of mitochondrial genetic material from the matrix into the cytosol or extracellular space, typically following a loss of mitochondrial membrane integrity. This phenomenon is often triggered by cellular stressors such as oxidative damage, the opening of the mitochondrial permeability transition pore (mPTP), or the formation of BAX/BAK macropores during apoptosis. Once in the cytosol, mtDNA acts as a damage-associated molecular pattern (DAMP) that is recognized by the cyclic GMP-AMP synthase (cGAS), which subsequently activates the STING (Stimulator of Interferon Genes) pathway. This signaling cascade induces the production of type I interferons and pro-inflammatory cytokines, initiating a potent innate immune response. Dysregulation of mitochondrial integrity and the resulting mtDNA leakage are central to the pathogenesis of numerous conditions, including neurodegenerative diseases like Parkinson's and Alzheimer's, cardiovascular disorders, and chronic inflammatory diseases. In oncology, mtDNA leakage can be exploited to stimulate anti-tumor immunity, although chronic leakage may also contribute to a pro-tumorigenic inflammatory environment. Therapeutic strategies targeting this process include the use of mPTP inhibitors like Cyclosporine A to prevent leakage, mitochondrial-targeted antioxidants like MitoQ to preserve integrity, and small-molecule inhibitors of cGAS or STING (e.g., H-151) to block downstream inflammatory signaling.

Other names

Mitochondrial integrity lossCytosolic mtDNA releaseMitochondrial DNA stressMitochondrial DNA-mediated inflammationMitochondrial membrane permeabilization

Inhibition of the mitochondrial permeability transition pore (mPTP), inhibition of cGAS-STING signaling, and reduction of mitochondrial oxidative stress.